Physician profile
Christopher David Collier
NPI 1649615816
$2,146.09
in general payments reported to CMS, 2019-2025
7 companies · $266 in 2025
The $266 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,615 · 2020: $45.78 · 2024: $219 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464 · Education: $21.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.66 |
| Education | $21.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,403.54 | 2019-2025 | T2 Alpha |
| W. L. Gore & Associates, INC. | $199.53 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Icotec Medical INC. | $145.32 | 2025 | Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm, Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm |
| Solventum Corporation | $118.81 | 2024-2025 | V.A.C.Ulta, Abthera, Prevena |
| Depuy Synthes Sales INC. | $116.92 | 2019 | |
| Onkos Surgical, INC. | $92.27 | 2019 | |
| Rock Medical Orthopedics, INC. | $69.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Collier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.